{"id":"W3211699349","doi":"10.1182/blood.2021012589","title":"Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Internal medicine; Clinical endpoint; Romiplostim; Platelet; Clinical trial; Thrombopoietin; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004359672,0.000562708,0.001119649,0.0002023416,0.0001267011,0.000150947,0.0004166928,0.0009076772,0.001239237],"category_scores_gemma":[0.0004321873,0.0003525923,0.0001615008,0.0003018043,0.0003912386,0.00009201225,0.0003624968,0.005581575,0.00004438297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001709564,"about_ca_system_score_gemma":0.001316523,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009141754,"about_ca_topic_score_gemma":0.001277895,"domain_scores_codex":[0.9962999,0.0006857514,0.0004870222,0.000971196,0.000871238,0.0006849415],"domain_scores_gemma":[0.9970961,0.001227179,0.0002327311,0.001150933,0.0001156468,0.0001774252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0200149,0.0006743933,0.005874372,0.0003073212,0.001554241,0.06473923,0.0005760079,4.29455e-7,0.0002937153,0.00000130511,0.9029393,0.003024843],"study_design_scores_gemma":[0.290454,0.003048843,0.0200251,0.001810804,0.002232625,0.002343416,0.0004172999,0.00001749086,0.001564543,0.00009931762,0.6768296,0.001156923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.8436882,0.001959199,0.000001381505,0.150747,0.0002010132,0.001309266,0.001094882,0.00005291222,0.0009461901],"genre_scores_gemma":[0.1950909,0.005800269,0.001174838,0.743125,0.03613908,0.0007468002,0.01240178,0.0006908416,0.004830526],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6485973,"threshold_uncertainty_score":0.9998926,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01509013717606393,"score_gpt":0.2427511755753923,"score_spread":0.2276610383993284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}